Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Jan;71(1):128–133. doi: 10.1038/bjc.1995.26

Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.

L Y Shih 1, P Dunn 1, W M Leung 1, W J Chen 1, P N Wang 1
PMCID: PMC2033434  PMID: 7819027

Abstract

The clinical features and response to therapy of 32 Chinese patients with localised plasmacytoma are presented, and a comparison between extramedullary plasmacytoma (EMP) and solitary plasmacytoma of bone (SPB) is made. Twenty-two patients had SPB and ten had EMP, accounting for 9% of all of our plasma cell neoplasms. Both groups had a male predominance with a median age of 54 years for SPB and 63 years for EMP. The common sites of SPB included vertebral bodies (15) and the skull (4). Most EMPs occurred in the oronasopharynx (6) and paranasal sinuses (2). An M-protein was detected in eight patients with SPB and in six with EMP. Seventeen patients with SPB and seven with EMP received radiation therapy, and all achieved initial local control. The pattern of failure in 22 patients with SPB manifested as local recurrence in two, multiple bone metastases without bone marrow plasmacytosis in two, multiple EMP progression in two, and development of multiple myeloma (MM) in one. There were two local recurrences, one further solitary bone involvement and one MM conversion in the EMP group. Local recurrence or dissemination was associated with the appearance of M-protein or an increase in the M-protein level in both groups. There was no significant difference in M-protein status or incidence and patterns of failure between the two groups. Patients with EMP had a more favourable overall survival than those with SPB (P = 0.03). The 5 year disease-free survival rate was 79% for EMP and 58% for SPB (P = 0.53). Patients aged less than 60 years had a better overall survival in the SPB group, but location of tumour, presence of M-protein, radiation dose and chemotherapy did not influence prognosis in either group. Our results indicate that adequate local therapy can result in long-term survival with a low frequency of MM progression for patients with localised plasmacytomas, and both EMP and SPB appear to be similar in terms of frequency and patterns of failure.

Full text

PDF
128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bataille R., Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer. 1981 Aug 1;48(3):845–851. doi: 10.1002/1097-0142(19810801)48:3<845::aid-cncr2820480330>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  2. Bergsagel D. E., Bailey A. J., Langley G. R., MacDonald R. N., White D. F., Miller A. B. The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia. N Engl J Med. 1979 Oct 4;301(14):743–748. doi: 10.1056/NEJM197910043011402. [DOI] [PubMed] [Google Scholar]
  3. Bush S. E., Goffinet D. R., Bagshaw M. A. Extramedullary plasmacytoma of the head and neck. Radiology. 1981 Sep;140(3):801–805. doi: 10.1148/radiology.140.3.6792654. [DOI] [PubMed] [Google Scholar]
  4. Chak L. Y., Cox R. S., Bostwick D. G., Hoppe R. T. Solitary plasmacytoma of bone: treatment, progression, and survival. J Clin Oncol. 1987 Nov;5(11):1811–1815. doi: 10.1200/JCO.1987.5.11.1811. [DOI] [PubMed] [Google Scholar]
  5. Corwin J., Lindberg R. D. Solitary plasmacytoma of bone vs. extramedullary plasmacytoma and their relationship to multiple myeloma. Cancer. 1979 Mar;43(3):1007–1013. doi: 10.1002/1097-0142(197903)43:3<1007::aid-cncr2820430333>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  6. Delauche-Cavallier M. C., Laredo J. D., Wybier M., Bard M., Mazabraud A., Le Bail Darne J. L., Kuntz D., Ryckewaert A. Solitary plasmacytoma of the spine. Long-term clinical course. Cancer. 1988 Apr 15;61(8):1707–1714. doi: 10.1002/1097-0142(19880415)61:8<1707::aid-cncr2820610832>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  7. Dimopoulos M. A., Goldstein J., Fuller L., Delasalle K., Alexanian R. Curability of solitary bone plasmacytoma. J Clin Oncol. 1992 Apr;10(4):587–590. doi: 10.1200/JCO.1992.10.4.587. [DOI] [PubMed] [Google Scholar]
  8. Ellis P. A., Colls B. M. Solitary plasmacytoma of bone: clinical features, treatment and survival. Hematol Oncol. 1992 May-Aug;10(3-4):207–211. doi: 10.1002/hon.2900100311. [DOI] [PubMed] [Google Scholar]
  9. Frassica D. A., Frassica F. J., Schray M. F., Sim F. H., Kyle R. A. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):43–48. doi: 10.1016/0360-3016(89)90008-4. [DOI] [PubMed] [Google Scholar]
  10. Greenberg P., Parker R. G., Fu Y. S., Abemayor E. The treatment of solitary plasmacytoma of bone and extramedullary plasmacytoma. Am J Clin Oncol. 1987 Jun;10(3):199–204. doi: 10.1097/00000421-198706000-00004. [DOI] [PubMed] [Google Scholar]
  11. Harwood A. R., Knowling M. A., Bergsagel D. E. Radiotherapy of extramedullary plasmacytoma of the head and neck. Clin Radiol. 1981 Jan;32(1):31–36. doi: 10.1016/s0009-9260(81)80242-5. [DOI] [PubMed] [Google Scholar]
  12. Holland J., Trenkner D. A., Wasserman T. H., Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer. 1992 Mar 15;69(6):1513–1517. doi: 10.1002/1097-0142(19920315)69:6<1513::aid-cncr2820690633>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  13. Jackson A., Scarffe J. H. Prognostic significance of osteopenia and immunoparesis at presentation in patients with solitary myeloma of bone. Eur J Cancer. 1990 Mar;26(3):363–371. doi: 10.1016/0277-5379(90)90235-l. [DOI] [PubMed] [Google Scholar]
  14. Knowling M. A., Harwood A. R., Bergsagel D. E. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol. 1983 Apr;1(4):255–262. doi: 10.1200/JCO.1983.1.4.255. [DOI] [PubMed] [Google Scholar]
  15. Kotner L. M., Wang C. C. Plasmacytoma of the upper air and food passages. Cancer. 1972 Aug;30(2):414–418. doi: 10.1002/1097-0142(197208)30:2<414::aid-cncr2820300217>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  16. Mayr N. A., Wen B. C., Hussey D. H., Burns C. P., Staples J. J., Doornbos J. F., Vigliotti A. P. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol. 1990 Apr;17(4):293–303. doi: 10.1016/0167-8140(90)90003-f. [DOI] [PubMed] [Google Scholar]
  17. Meis J. M., Butler J. J., Osborne B. M., Ordóez N. G. Solitary plasmacytomas of bone and extramedullary plasmacytomas. A clinicopathologic and immunohistochemical study. Cancer. 1987 Apr 15;59(8):1475–1485. doi: 10.1002/1097-0142(19870415)59:8<1475::aid-cncr2820590814>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  18. Mendenhall C. M., Thar T. L., Million R. R. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1980 Nov;6(11):1497–1501. doi: 10.1016/0360-3016(80)90006-1. [DOI] [PubMed] [Google Scholar]
  19. Meyer J. E., Schulz M. D. "Solitary" myeloma of bone: a review of 12 cases. Cancer. 1974 Aug;34(2):438–440. doi: 10.1002/1097-0142(197408)34:2<438::aid-cncr2820340230>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  20. Mill W. B., Griffith R. The role of radiation therapy in the management of plasma cell tumors. Cancer. 1980 Feb 15;45(4):647–652. doi: 10.1002/1097-0142(19800215)45:4<647::aid-cncr2820450405>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  21. Pahor A. L. Extramedullary plasmacytoma of the head and neck, parotid and submandibular salivary glands. J Laryngol Otol. 1977 Mar;91(3):241–258. doi: 10.1017/s0022215100083626. [DOI] [PubMed] [Google Scholar]
  22. Petrovich Z., Fishkin B., Hittle R. E., Acquarelli M., Barton R. Extramedullary plasmacytoma of the upper respiratory passages. Int J Radiat Oncol Biol Phys. 1977 Jul-Aug;2(7-8):723–730. doi: 10.1016/0360-3016(77)90054-2. [DOI] [PubMed] [Google Scholar]
  23. Tong D., Griffin T. W., Laramore G. E., Kurtz J. M., Russell A. H., Groudine M. T., Herron T., Blasko J. C., Tesh D. W. Solitary plasmacytoma of bone and soft tissues. Radiology. 1980 Apr;135(1):195–198. doi: 10.1148/radiology.135.1.7360960. [DOI] [PubMed] [Google Scholar]
  24. Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore) 1976 May;55(3):217–238. doi: 10.1097/00005792-197605000-00002. [DOI] [PubMed] [Google Scholar]
  25. Wollersheim H. C., Holdrinet R. S., Haanen C. Clinical course and survival in 16 patients with localized plasmacytoma. Scand J Haematol. 1984 Apr;32(4):423–428. doi: 10.1111/j.1600-0609.1984.tb00699.x. [DOI] [PubMed] [Google Scholar]
  26. Woodruff R. K., Malpas J. S., White F. E. Solitary plasmacytoma. II: Solitary plasmacytoma of bone. Cancer. 1979 Jun;43(6):2344–2347. doi: 10.1002/1097-0142(197906)43:6<2344::aid-cncr2820430626>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  27. Woodruff R. K., Whittle J. M., Malpas J. S. Solitary plasmacytoma. I: Extramedullary soft tissue plasmacytoma. Cancer. 1979 Jun;43(6):2340–2343. doi: 10.1002/1097-0142(197906)43:6<2340::aid-cncr2820430625>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES